E

Esperion Therapeutics
D

ESPR

2.20000
USD
-0.06
(-2.44%)
مغلق
حجم التداول
66,611
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
433,477,376
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -2.740
    (-1.10%)
    246.360 USD
    AMGN
    AMGN
    2.84
    (1.05%)
    272.25 USD
    I
    INCY
    -0.500
    (-0.69%)
    71.950 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    S
    SGEN
    0
    (0%)
    0 USD
    VRTX
    VRTX
    4.97
    (1.19%)
    422.10 USD
    المزيد
الأخبار
المقالات

العنوان: Esperion Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.